GH Research (GHRS) Interest Income - Net (2022 - 2025)
GH Research (GHRS) posted quarterly Interest Income - Net of $3.6 million for Q4 2025, up 269.94% year-over-year from $962851.7 in Q4 2024, and down 75.49% quarter-over-quarter from $14.5 million in Q3 2025.
GH Research (GHRS) Interest Income - Net (2022 - 2025) Analysis & Trends
GH Research's Interest Income - Net history runs 4 years deep, the most recent figure standing at $3.6 million for Q4 2025.
- In Q4 2025, Interest Income - Net rose 269.94% year-over-year to $3.6 million; the TTM figure through Dec 2025 stood at $11.9 million (up 223.09% YoY), while the FY2025 annual figure was $12.7 million, up 238.79% from the prior year.
- Interest Income - Net for Q4 2025 stood at $3.6 million, down from $14.5 million in the prior quarter.
- The five-year high for Interest Income - Net was $14.5 million in Q3 2025, with the low at -$3.2 million in Q2 2025.
- The 4-year median for Interest Income - Net is -$2.4 million (2024), against an average of -$600384.6.
- The sharpest annual moves came in 2023 and 2025: Interest Income - Net tumbled 156.14% in 2023, then jumped 717.29% in 2025.
- GH Research's Interest Income - Net stood at -$1.2 million in 2022, then sank by 156.14% to -$3.0 million in 2023, then surged by 31.12% to -$2.1 million in 2024, then soared by 269.94% to $3.6 million in 2025.
- Business Quant data shows GHRS's Interest Income - Net at $3.6 million in Q4 2025, $14.5 million in Q3 2025, and -$3.2 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Income - Net (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | GH Research | 2.02 Bn | 1.68 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.56 Mn |
| Sep 30, 2025 | 14.53 Mn |
| Jun 30, 2025 | -3.25 Mn |
| Mar 31, 2025 | -2.94 Mn |
| Dec 31, 2024 | -2.10 Mn |
| Sep 30, 2024 | -2.35 Mn |
| Jun 30, 2024 | -2.73 Mn |
| Mar 31, 2024 | -2.49 Mn |
| Dec 31, 2023 | -3.04 Mn |
| Sep 30, 2023 | -2.62 Mn |
| Jun 30, 2023 | -1.94 Mn |
| Mar 31, 2023 | -1.24 Mn |
| Dec 31, 2022 | -1.19 Mn |